We use cookies on this site to enable your digital experience. By continuing to use this site, you are agreeing to our cookie policy. close

Analysis

Patent-Busting A Hard Sell For Public Health Activists

Law360 (February 25, 2019, 7:22 PM EST) -- Frustrated with high drug prices, local government officials and activists are urging the federal government to use its power to sidestep or break up patents on expensive drugs. Yet they're up against decades of evidence the government has no desire to do so.

The issue is receiving renewed attention after the speaker of the New York City Council and other city politicians last week joined calls for the National Institutes of Health to "break the patent" on Gilead Sciences Inc.'s Truvada, an HIV prevention pill.

"As an HIV+ elected official, I have a responsibility to the activists who came before me...

Stay ahead of the curve

In the legal profession, information is the key to success. You have to know what’s happening with clients, competitors, practice areas, and industries. Law360 provides the intelligence you need to remain an expert and beat the competition.


  • Access to case data within articles (numbers, filings, courts, nature of suit, and more.)
  • Access to attached documents such as briefs, petitions, complaints, decisions, motions, etc.
  • Create custom alerts for specific article and case topics and so much more!

TRY LAW360 FREE FOR SEVEN DAYS